GF Fund Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.8K Sell
3,372
-252
-7% -$5K ﹤0.01% 366
2026
Q1
$69.7K Sell
3,624
-349
-9% -$6.87K ﹤0.01% 368
2025
Q4
$75.2K Sell
3,973
-20
-0.5% -$371 ﹤0.01% 369
2025
Q3
$74.4K Sell
3,993
-203
-5% -$3.79K ﹤0.01% 359
2025
Q2
$77.4K Sell
4,196
-285
-6% -$5.06K ﹤0.01% 387
2025
Q1
$78.3K Buy
4,481
+224
+5% +$3.78K ﹤0.01% 382
2024
Q4
$73.7K Buy
+4,257
New +$77.7K ﹤0.01% 355

Other funds holding SBRA

GF Fund Management's SBRA Position: Q2 2026 in Review

GF Fund Management reduced its Sabra Healthcare REIT (SBRA) stake by 7% in Q2 2026, selling an estimated $5K and leaving 3,372 shares worth $65.8K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

GF Fund Management first reported a position in SBRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $78.3K in Q1 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • GF Fund Management held 3,372 shares of Sabra Healthcare REIT worth $65.8K as of Q2 2026.
  • GF Fund Management sold 252 Sabra Healthcare REIT shares in Q2 2026, an estimated $5K.
  • Sabra Healthcare REIT made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #366 holding.
  • GF Fund Management first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Sabra Healthcare REIT position peaked at $78.3K in Q1 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.